Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rewriting the cancer proteome: targeting selective translation as a therapeutic frontier.

The Journal of clinical investigation·2026

Same author

Ribo-Tweezer: Rapid removal of ribosomal proteins reveals additional layers of post-transcriptional gene regulation.

Molecular cell·2026

Same author

Metabolic and transcriptional plasticity supports CD8<sup>+</sup> T cell resilience and anti-tumor immunity under nutrient stress.

Immunity·2026

Same author

SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies.

bioRxiv : the preprint server for biology·2026

Same author

A Legacy of Mentorship: A Tribute to Lewis Cantley.

Cancer discovery·2026

Same author

Environmental Amino Acid Sensing Regulates the Rate of ASC Translation and NLRP3 Inflammasome Assembly.

bioRxiv : the preprint server for biology·2026

Same journal

Advancing microalgae biomass cultivation for an integrated sustainable wastewater treatment and resource recovery.

iScience·2026

Same journal

Corrigendum to "Human adipose ECM alleviates radiation-induced skin fibrosis via endothelial cell-mediated M2 macrophage polarization" [iScience, Volume 26, Issue 9 (2023) 107660].

iScience·2026

Same journal

High-definition transcranial direct current stimulation enhances exercise-induced hypoalgesia in patients with chronic low back pain.

iScience·2026

Same journal

From pre-tumor to tumor: Decoding the endoscopic-pathologic spectrum of neoplastic lesions in autoimmune gastritis.

iScience·2026

Same journal

Corrigendum to "A cobalt-aluminium layered double hydroxide with a nickel core-shell structure nanocomposite for supercapacitor applications" [iScience, 28 (2025) 111672].

iScience·2026

Same journal

Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway.

iScience·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 28, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function.

Honyin Chiu¹, Roberta Buono¹, Leandra V Jackson¹

¹Department of Molecular Biology & Biochemistry, University of California, Irvine, CA 92697, USA.

|July 19, 2021

Summary

This summary is machine-generated.

Reducing eukaryotic initiation factor 4E (eIF4E) impairs B-cell leukemia growth. This targeted inhibition spares normal B-cell development and function, suggesting eIF4E as a promising therapeutic strategy for leukemia.

Keywords:

cancer cell biology molecular biology

More Related Videos

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Related Experiment Videos

Last Updated: Oct 28, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

Area of Science:

Oncology
Molecular Biology
Immunology

Background:

Eukaryotic initiation factor 4E (eIF4E) is a cap-binding protein.
eIF4E promotes translation of mRNAs linked to cell proliferation and survival.
eIF4E is a potential target for cancer therapeutics.

Purpose of the Study:

To investigate the impact of reduced eIF4E gene dosage on B-cell leukemogenesis.
To compare the effects of reduced eIF4E on leukemia versus normal B-cell function.
To evaluate eIF4E as a therapeutic target for pre-B-cell leukemia.

Main Methods:

Utilized Eif4e germline and conditional knockout mouse models.
Employed a BCR-ABL-driven pre-B-cell leukemia model.
Conducted in vitro and in vivo competition assays.

Main Results:

Loss of one Eif4e allele impaired leukemic cell transformation and fitness.
Reduced Eif4e gene dosage did not significantly affect normal pre-B and mature B-cell development.
Normal non-transformed B lineage cell survival and proliferation were unaffected by reduced Eif4e.

Conclusions:

Inhibition of eIF4E shows therapeutic potential for pre-B-cell leukemia.
Targeting eIF4E may preserve normal B-cell development and function.
Reduced eIF4E gene dosage selectively impacts leukemic cells over normal B cells.